Table 2.
Adverse events | Adjuvant Lenvatinib (n = 57) | |||
---|---|---|---|---|
All | Grade 1 | Grade 2 | Grade 3 | |
Hypertension | 20 | 10 | 7 | 3 |
PPES | 13 | 7 | 5 | 1 |
Diarrhoea | 19 | 9 | 8 | 2 |
Fatigue | 15 | 9 | 6 | 0 |
Decreased appetite | 16 | 7 | 9 | 0 |
Hypothyroidism | 6 | 4 | 2 | 0 |
DILI | 17 | 10 | 6 | 1 |
Others | 10 | 7 | 3 | 0 |
PPES, palmar-plantar erythrodysesthesia syndrome; DILI, drug-induced liver injury.